ANIP
HealthcareANI Pharmaceuticals, Inc.
$78.66
+$0.23 (+0.29%)
Jan 5, 2026
Price History (1Y)
Analysis
ANI Pharmaceuticals, Inc. is a company within the healthcare sector, operating in the drug manufacturers - specialty & generic industry. It has a market capitalization of $1.77 billion and generates revenue of $826.88 million (TTM), employing 897 individuals. The company's financial health indicates moderate profitability, with gross margin at 60.8%, operating margin at 10.2%, and profit margin at 4.9%. Returns on equity and assets are 8.7% and 2.5%, respectively. The balance sheet reveals a significant amount of debt ($631.58 million) compared to cash reserves ($271.47 million), resulting in a debt-to-equity ratio of 124.86. The valuation context for ANI Pharmaceuticals, Inc. includes a price-to-earnings ratio (TTM) of 48.86 and forward P/E of 9.23. The company has experienced revenue growth of 53.6% year-over-year, but earnings growth is not available. Dividend information is not provided.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Visit website →Key Statistics
- Market Cap
- $1.77B
- P/E Ratio
- 48.86
- 52-Week High
- $99.50
- 52-Week Low
- $52.74
- Avg Volume
- 401.28K
- Beta
- 0.51
Company Info
- Exchange
- NGM
- Country
- United States
- Employees
- 897